Literature DB >> 3104178

Intestinal permeability changes in rodents: a possible mechanism for degraded carrageenan-induced colitis.

T Delahunty, L Recher, D Hollander.   

Abstract

Rats and guinea-pigs were treated with degraded carrageenan (50 g/litre in the drinking-water) and their intestinal permeability was studied at weekly intervals over the last 4 wk of the test period by determining the recovery of orally administered tracer doses of [3H]polyethylene glycol (PEG-900) or D-[3H]mannitol in 16-hr urine collections. A freely diffusible dye, Azure A, was administered simultaneously to compensate for non-intestinal factors that could modify renal excretion. Animals were killed after a total treatment period of 5 months for rats and 6 wk for guinea-pigs. After 3 wk of carrageenan treatment, excretion of PEG-900 (expressed as a ratio of the Azure A excretion) in guinea-pigs showed a statistically significant increase over that in the control group. At autopsy, the caeca showed numerous macroscopically visible erosions of the entire mucosal surface and histological examination showed ulcerations largely in the mucosa with abscesses in the crypts. Although no such histological changes were seen in the intestines of the treated rats, even after 5 months, a statistically significant increase in PEG-900 excretion was again found compared with the control group. This increase did not occur when deoxycholate was administered with the carrageenan solution. No effect of carrageenan treatment on mucosal permeability to D-[3H]mannitol was demonstrated in either species. The results suggest that degraded carrageenan-induced colitis could be a result of increased intestinal permeability, since ingestion of this polysaccharide by rats increased PEG-900 absorption without causing mucosal damage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104178     DOI: 10.1016/0278-6915(87)90143-8

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  5 in total

Review 1.  The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease.

Authors:  Christopher A Lamb; Aamir Saifuddin; Nick Powell; Florian Rieder
Journal:  Gastroenterology       Date:  2022-01-04       Impact factor: 22.682

2.  The pre-ulcerative phase of carrageenan-induced colonic ulceration in the guinea-pig.

Authors:  S N Marcus; A J Marcus; R Marcus; S W Ewen; J Watt
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

3.  Colitis and colonic mucosal barrier dysfunction.

Authors:  K R Gardiner; N H Anderson; B J Rowlands; A Barbul
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

Review 4.  Review of harmful gastrointestinal effects of carrageenan in animal experiments.

Authors:  J K Tobacman
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

5.  Cytotoxicity effect of degraded and undegraded kappa and iota carrageenan in human intestine and liver cell lines.

Authors:  Shahrul Hisham Zainal Ariffin; Wong Woan Yeen; Intan Zarina Zainol Abidin; Rohaya Megat Abdul Wahab; Zaidah Zainal Ariffin; Sahidan Senafi
Journal:  BMC Complement Altern Med       Date:  2014-12-17       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.